5-HT receptors mediating contractions of the isolated human coronary artery

https://doi.org/10.1016/0014-2999(93)90995-TGet rights and content

Abstract

We investigated contractile responses of the isolated human coronary artery to 5-hydroxytryptamine (5-HT), washed human platelets, sumatriptan and ergotamine. 5-HT (pD2: 6.8 ± 0.1, Emax: 47.7 ± 6.8 mN) and platelets (effect 14.4 ± 2.8 mN with 3 · 1010 platelets/1) caused contractile responses which were attenuated by ketanserin (1 μM). In the presence of ketanserin (1 μM), both rauwolscine (1 and 10 μM) and cyanopindolol (1 and 10 μM) caused concentration-dependent additional antagonism against contractions induced by low (⩽ 1 μM) concentrations of 5-HT. Sumatriptan-induced contractions (pD2: 6.2 ± 0.1; Emax: 10.7 ± 2.4 mN) were antagonized to a similar extent by both rauwolscine (1 μM) and cyanopindolol (1 μM) (pKB: 6.5 ± 0.1 and 6.4 ± 0.1, respectively) and also by metergoline (0.1 μM; pKB: 7.2 ± 0.1). The order of potency of antagonists against sumatriptan resembles the order reported for the human saphenous vein 5-HT1D-like receptor. No significant additional antagonism by cyanopindolol (1 μM) or rauwolscine (1 μM) against platelet-induced contractile responses was observed. Ergotamine caused potent contractile responses (pD2: 8.4 ± 0.3, Emax: 19.4 ± 2.4 mN). It is concluded that although 5-HT2 receptors predominantly mediate 5-HT-induced contractions, the 5-HT1-like receptor seems to play a role in coronary vasospasm caused by low concentrations of 5-HT.

References (41)

  • R. De Catarina et al.

    A doubleblind, placebo-controlled study of ketanserin in patients with Prinzmetal's angina: evidence against a role for serotonin in the genesis of coronary vasospasm

    Circulation

    (1984)
  • F. De Clerk et al.

    Platelet-mediated vascular contractions; inhibition by flunarizine, a calcium-entry blocker

    Biochem. Pharmacol.

    (1983)
  • A. De Lean et al.

    Simultaneous analysis of families of sigmoidal curves: application of bioassay, radioligand assay and physiological dose-response curves

    Am. J. Physiol.

    (1978)
  • M.O. Den Boer et al.

    Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT receptors

    Br. J. Pharmacol.

    (1991)
  • J.R. Docherty et al.

    An examination of 5-hydroxytryptamine receptors in human saphenous vein

    Br. J. Pharmacol.

    (1986)
  • W. Feniuk et al.

    Comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists

    Br. J. Pharmacol.

    (1985)
  • U. Förstermann et al.

    Selective attenuation of endothelium-mediated vasodilatation in atherosclerotic human coronary arteries

    Circ. Res.

    (1988)
  • U. Förstermann et al.

    Response of human coronary arteries to aggregating platelets: importance of endothelium-derived relaxing factor and prostanoids

    Circ. Res.

    (1988)
  • S.B. Freedman et al.

    Ergonovine-induced myocardial ischemia: no role for serotonergic receptors?

    Circulation

    (1984)
  • R.F. Furchgott

    The classification of adrenoceptors. An evaluation from the standpoint of receptor theory

  • Cited by (75)

    • Migraine

      2022, Comprehensive Pharmacology
    • Pharmacological analysis of contractile effects of eletriptan and sumatriptan on human isolated blood vessels

      2000, European Journal of Pharmacology
      Citation Excerpt :

      The exact nature of this additional mechanism involved in eletriptan-induced contraction is unknown, but it is conceivable that a part of the contraction to high concentrations of eletriptan, particularly after blockade of the 5-HT1B receptor by GR125743, may be mediated via the 5-HT2A receptor. In contrast to the human middle meningeal artery that predominantly possesses 5-HT1B receptor population (Jansen et al., 1992; Razzaque et al., 1999), it is known that both human coronary artery and saphenous vein have a mixed population of 5-HT1B and 5-HT2 receptors (Connor et al., 1989; Bax et al., 1992, 1993; Ishida et al., 1999; Nilsson et al., 1999b). We must, however, concede that eletriptan does not differ from sumatriptan with regard to the affinity at the 5-HT2A receptor (pKi: both <5.5, Napier et al., 1999).

    • The effect of Sumatriptan in ischemic conditions in the rat heart

      2018, Turkish Journal of Pharmaceutical Sciences
    View all citing articles on Scopus
    View full text